CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia
Continuous Glucose Monitoring: An Evaluation of Impact on Improving the Efficiency of Diagnostic Processes and Enhancing Patient Safety in the Management of Reactive and Spontaneous Hypoglycaemia
Sponsor: Barts & The London NHS Trust
Terminated
Due to the Covid crisis: clinical changes in staff, bed pressures and time restraints.
Other terminated trials from Barts & The London NHS Trust
This NA trial investigates Hypoglycaemia Night and Hypoglycemia Non-Diabetic and is currently terminated or withdrawn. Barts & The London NHS Trust leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2024 — Jul 2024 [monthly]
Terminated NA
-
Dec 2023 — Jan 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Oct 2021 — Dec 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Barts & The London NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .